427 related articles for article (PubMed ID: 32341068)
1. Glutamatergic Systems and Memory Mechanisms Underlying Opioid Addiction.
Heinsbroek JA; De Vries TJ; Peters J
Cold Spring Harb Perspect Med; 2021 Mar; 11(3):. PubMed ID: 32341068
[TBL] [Abstract][Full Text] [Related]
2. The role of glutamate and its receptors in mesocorticolimbic dopaminergic regions in opioid addiction.
Guo Y; Wang HL; Xiang XH; Zhao Y
Neurosci Biobehav Rev; 2009 Jun; 33(6):864-73. PubMed ID: 19428497
[TBL] [Abstract][Full Text] [Related]
3. Topiramate-chitosan nanoparticles prevent morphine reinstatement with no memory impairment: Dopaminergic and glutamatergic molecular aspects in rats.
Milanesi LH; Rossato DR; Oliveira da Rosa JL; D'avila LF; Metz VG; Wolf JF; Reis VB; de Andrade DF; Jank L; Beck RCR; da Silva CB; Burger ME
Neurochem Int; 2021 Nov; 150():105157. PubMed ID: 34390773
[TBL] [Abstract][Full Text] [Related]
4. Morphine treatment enhances glutamatergic input onto neurons of the nucleus accumbens via both disinhibitory and stimulating effect.
Yuan K; Sheng H; Song J; Yang L; Cui D; Ma Q; Zhang W; Lai B; Chen M; Zheng P
Addict Biol; 2017 Nov; 22(6):1756-1767. PubMed ID: 27549902
[TBL] [Abstract][Full Text] [Related]
5. Opiate exposure and withdrawal induces a molecular memory switch in the basolateral amygdala between ERK1/2 and CaMKIIα-dependent signaling substrates.
Lyons D; de Jaeger X; Rosen LG; Ahmad T; Lauzon NM; Zunder J; Coolen LM; Rushlow W; Laviolette SR
J Neurosci; 2013 Sep; 33(37):14693-704. PubMed ID: 24027270
[TBL] [Abstract][Full Text] [Related]
6. Inter-individual differences in serotonin and glutamate co-transmission reflect differentiation in context-induced conditioned 50-kHz USVs response after morphine withdrawal.
Hamed A; Kursa MB
Brain Struct Funct; 2018 Sep; 223(7):3149-3167. PubMed ID: 29774428
[TBL] [Abstract][Full Text] [Related]
7. Cellular neuroadaptations to chronic opioids: tolerance, withdrawal and addiction.
Christie MJ
Br J Pharmacol; 2008 May; 154(2):384-96. PubMed ID: 18414400
[TBL] [Abstract][Full Text] [Related]
8. Rewarding morphine-induced synaptic function of delta-opioid receptors on central glutamate synapses.
Bie B; Zhu W; Pan ZZ
J Pharmacol Exp Ther; 2009 Apr; 329(1):290-6. PubMed ID: 19168708
[TBL] [Abstract][Full Text] [Related]
9. Serotonin-1A receptor dependent modulation of pain and reward for improving therapy of chronic pain.
Haleem DJ
Pharmacol Res; 2018 Aug; 134():212-219. PubMed ID: 29969666
[TBL] [Abstract][Full Text] [Related]
10. Opiate exposure state controls dopamine D3 receptor and cdk5/calcineurin signaling in the basolateral amygdala during reward and withdrawal aversion memory formation.
Rosen LG; Rushlow WJ; Laviolette SR
Prog Neuropsychopharmacol Biol Psychiatry; 2017 Oct; 79(Pt B):59-66. PubMed ID: 28627448
[TBL] [Abstract][Full Text] [Related]
11. Glutamate: the new frontier in pharmacotherapy for cocaine addiction.
Uys JD; LaLumiere RT
CNS Neurol Disord Drug Targets; 2008 Nov; 7(5):482-91. PubMed ID: 19128205
[TBL] [Abstract][Full Text] [Related]
12. Computational modeling of opioid-induced synaptic plasticity in hippocampus.
Borjkhani M; Bahrami F; Janahmadi M
PLoS One; 2018; 13(3):e0193410. PubMed ID: 29513763
[TBL] [Abstract][Full Text] [Related]
13. Enhanced opioid efficacy in opioid dependence is caused by an altered signal transduction pathway.
Ingram SL; Vaughan CW; Bagley EE; Connor M; Christie MJ
J Neurosci; 1998 Dec; 18(24):10269-76. PubMed ID: 9852564
[TBL] [Abstract][Full Text] [Related]
14. Glutamate mechanisms underlying opiate memories.
Peters J; De Vries TJ
Cold Spring Harb Perspect Med; 2012 Sep; 2(9):a012088. PubMed ID: 22951449
[TBL] [Abstract][Full Text] [Related]
15. The Raphe Dopamine System Controls the Expression of Incentive Memory.
Lin R; Liang J; Wang R; Yan T; Zhou Y; Liu Y; Feng Q; Sun F; Li Y; Li A; Gong H; Luo M
Neuron; 2020 May; 106(3):498-514.e8. PubMed ID: 32145184
[TBL] [Abstract][Full Text] [Related]
16. Non-Opioid Treatments for Opioid Use Disorder: Rationales and Data to Date.
Chalhoub RM; Kalivas PW
Drugs; 2020 Oct; 80(15):1509-1524. PubMed ID: 32776315
[TBL] [Abstract][Full Text] [Related]
17. Enhanced ability of TRPV1 channels in regulating glutamatergic transmission after repeated morphine exposure in the nucleus accumbens of rat.
Zhang H; Jia D; Wang Y; Qu L; Wang X; Song J; Heng L; Gao G
Brain Res; 2017 Apr; 1660():47-57. PubMed ID: 28188777
[TBL] [Abstract][Full Text] [Related]
18. Cellular and behavioral basis of cannabinioid and opioid interactions: Implications for opioid dependence and withdrawal.
Mohammadkhani A; Borgland SL
J Neurosci Res; 2022 Jan; 100(1):278-296. PubMed ID: 33352618
[TBL] [Abstract][Full Text] [Related]
19. Allostatic Changes in the cAMP System Drive Opioid-Induced Adaptation in Striatal Dopamine Signaling.
Muntean BS; Dao MT; Martemyanov KA
Cell Rep; 2019 Oct; 29(4):946-960.e2. PubMed ID: 31644915
[TBL] [Abstract][Full Text] [Related]
20. Mu-opioid receptor activation induces transcriptional plasticity in the central extended amygdala.
Befort K; Filliol D; Ghate A; Darcq E; Matifas A; Muller J; Lardenois A; Thibault C; Dembele D; Le Merrer J; Becker JA; Poch O; Kieffer BL
Eur J Neurosci; 2008 Jun; 27(11):2973-84. PubMed ID: 18588537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
